The global blood fluid warming system market is expected to witness significant growth during the forecast period. The market is driven by growing demand for blood fluid warming systems due to rise in hypothermia cases. Hypothermia prevails more in cold regions and is more commonly found in geriatric and infant population. Additionally, increase in surgical procedures along with aging population is the biggest factor propelling the market growth. Moreover, rise in consumption of drugs, increasing prevalence of thyroid and diabetes are other factors boosting the demand of blood fluid warming system market. Last but not the least, mergers and acquisitions among the market players is bolstering the market growth.
In the cold countries, adaptation is much severe and unfavorable. During cold winters, the inhabitants might suffer from hypothermia due to prolonged exposure to lower and freezing temperatures. Hypothermia usually happens due to loss of much heat from the body and symptoms mainly depend on the temperature.
Hypothermia can mainly happen due to two reasons, first, hypothermia usually takes place due to severe cold and secondly due to a condition that increases heat loss in the body. The body temperature nearly falls and the person suffers from prolonged shivering. Hence, to avoid such conditions, warm clothing is preferred. Intake of excessive alcohol, low blood sugar and aging are the additional factors that may lead to a hypothermic state.
Blood warmer is a device used particularly to warm blood or fluids in prior for transferring blood to a person. It basically works by warming the blood to a temperature that is mainly considered safe for infusion. The device is particularly used in ICUs, hospitals, clinical institutions, and operating rooms to prevent hypothermic condition. Blood warmers come with interesting features that enable its ease of accessibility, portability and patient’s comfort.
However, heavy R&D expenses in product development and lower awareness about blood and fluid warming instruments in the developing countries is expected to hinder the market growth of global blood and fluid warmer market. The blood fluid market is expected to witness a higher CAGR growth owing to increasing applications and a large number of population suffering from chronic ailments like diabetes, alcoholism etc., etc., Market entrants and technological developments in the global blood fluid warming market is projected to create a heavy competition in the global market.
On the basis of product, the global blood fluid warming systems market is segmented into surface warming system, intravenous warming system and patient warming accessories. Surface warming segment is expected to drive the market and account for a larger share owing to its increased adoption in the developed economies. On the basis of distribution channel, the global blood fluid warming system market is segmented into clinics, hospitals and e-commerce.
On the basis of application, the global blood fluid warming system market is segmented into preoperative care, new born care, acute care and home care. Acute care segment dominates the global market share due to rise in geriatric population with various diseases. On the basis of geographic segmentation, the global blood fluid warming system market spans North America, Europe, Asia-Pacific, Middle-East and Africa.North America dominates the global blood fluid warming market in terms of value added services.
The key players in the global blood fluid warming system market include GE Healthcare, Emit Corporation, Meridian Medical Systems, The 3M Company,CareFusion, Smiths Medical, The 37Company, Foshan Keewell and Barkey GmbH, Becton, Dickinson and Company.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.